The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.
|Articles|June 17, 2022
News Roundup: June 13 to June 17
Author(s)Miranda Hester
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
Next-In-Class Treatments Lead Oncology Drug Pipeline Update
The pipeline includes next-in-class treatments for melanoma, NSCLC, breast cancer, and multiple myeloma.
Hacking Diabetes: The DIY Bionic Pancreas Is Here to Stay
A do-it-yourself option to replace traditional diabetes management technology is growing in popularity.
Craving Connection, Pharmacists Celebrate a Return to In-Person Events
Transformation was top of mind at the 2022 American Associated Pharmacies (AAP) Annual Conference, where industry leaders, pharmacy owners, and AAP staff came together to celebrate their first annual meeting—live and in-person—since 2019.
FDA Approves Baricitinib Oral Tablets as First Systemic Alopecia Areata Treatment
The drug has previously been approved to treat moderately to severely active rheumatoid arthritis.
Integrated Health System Pharmacy Models Associated With Medication Adherence, Fewer Side Effects
Patient reported outcomes for were positive for those who filled medications at an integrated health system specialty pharmacy.
Advertisement
Related to this article
The Milken Institute released survey results alongside new data regarding the need for pharmacists in extending effective GLP-1 care.
Through the ACCESS program, Mark Ey, RPh, notes that pharmacies can now start billing for a variety of services they’ve already been providing.
The medication significantly increased risk of pregnancy loss when compared with macrolide antibiotics, amoxicillin, and topical clindamycin for acne.
In part 3, Rebold explores improving the ART formulary protocol through introducing pharmacist-led transition-of-care services.
Our hosts explore why ketone monitoring matters, what pharmacists should know about Libre Duo, and how patient education can support proactive care management.
Mark Ey, RPh, details the patient-focused factors of the ACCESS to Pharmacy Care Program and the ways in which valued care translates to reimbursement.
A new option for adults who have experienced stroke will now be available to further reduce future risk.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Adds NAION Eye Risk Warning to All GLP-1 Labels
2
The Pharmacy Model Creating New Billing Pathways, Improved Recognition
3
Doxycycline Use Associated with Higher Risk of Pregnancy Loss
4
Wicked Good Cardiometabolic Chat: Ketone Monitoring in Pharmacy Practice
5